Triamcinolone Acetonide Injection shortage (resolved)
Triamcinolone Acetonide Injection is not in an active FDA shortage right now. The most recent status on record was “Resolved”. This page is kept for history. This page was last refreshed from FDA data on Sep 22, 2026.
Triamcinolone Acetonide Injection is not in an active FDA shortage right now (last status: “Resolved”) — confirm current availability with your pharmacy.
Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →What’s in shortage — at a glance
These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Triamcinolone Acetonide Injection. Other makers that haven’t reported a problem are shown in the green card below.
Shortage timeline
-
Jul 31, 2026Shortage resolvedFDA no longer lists this as an active shortage.
-
Sep 27, 2021First reported to the FDA1 product first listed.
Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.
What exactly is on backorder — by manufacturer
Manufacturer: Harrow Eye, LLC 📞 (615) 733-4734 1 NDC click to expand
| Status | NDC / product | Strength / size | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Resolved | Triesence, Injection, 40 mg/1 mL (NDC 82667-800-01) | — | — | — | — |
These rows are manufacturer reports to the FDA for Triamcinolone Acetonide Injection — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Triamcinolone Acetonide Injection? options further down this page.
Why is Triamcinolone Acetonide Injection in shortage?
Harrow Eye, LLC has reported this product to the FDA's shortage list, but they have not shared a specific public reason for why it's there. That kind of limited detail does happen sometimes — manufacturers aren't always required to explain the "why" beyond filing the report.
What I can tell you is that according to this report, Harrow Eye's Triesence (triamcinolone acetonide injection, 40 mg/1 mL) is currently listed as available, which is a good sign. This report reflects only what Harrow Eye has filed with the FDA — it doesn't speak to other manufacturers of this medicine.
Based on the manufacturer-reported reason(s) and notes on file with the FDA for Triamcinolone Acetonide Injection, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.
What should I do if I take Triamcinolone Acetonide Injection?
Triamcinolone Acetonide Injection is currently on the FDA drug-shortage list. I want to walk you through what this means for the strength you may use.
The one strength covered here, 40 mg/1 mL, still has an available source. There are no strengths of this injection listed as having no available source right now. In other words, every currently listed version of this product has supply reported.
This shortage has been recorded for over a year, but the picture remains steady: the single manufacturer on this record, Harrow Eye, LLC, reports its 40 mg/1 mL product (Triesence) as available, and none of the listed products are marked unavailable. That is a reassuring sign for continued access.
Here is what I suggest:
- Do not stop, skip, or change your doses on your own.
- Since your strength still has supply, ask your pharmacy to order it — pharmacies can check wholesalers and manufacturers.
- If needed, your pharmacy may also be able to source the same medicine from another maker, such as the Triesence or Xipere products listed on this page, though these may not be in local stock.
- If you cannot find your exact product, ask your prescriber or pharmacist about options.
Manufacturer contact numbers are listed on this page for reference; pharmacies usually handle these calls. This is general national information and may not match your local pharmacy's actual stock.
- Don’t stop or change the medication on your own — talk to your prescriber first.
- If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
- Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
- Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.
Where else can I get Triamcinolone Acetonide Injection?
FDA shortages are manufacturer-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every maker of Triamcinolone Acetonide Injection is necessarily short. Below we pull together the other still-marketed options that are not reported in shortage: the same medicine from manufacturers that haven’t reported a problem, and alternative dosage forms. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.
Same medicine, other manufacturers (not reported short)
Same active ingredient, dosage form & route as the shortage (matched on the FDB HICL ingredient code), from makers that have not filed a shortage with the FDA:
| Product | Strength | Form / route | Manufacturer | NDC |
|---|---|---|---|---|
| Triesence | TRIAMCINOLONE ACETONIDE 40 mg/mL | Injection, Suspension · Ophthalmic | Novartis Pharmaceuticals Corporation | 00078-0897-78 |
| Xipere | TRIAMCINOLONE ACETONIDE 40 mg/mL | Injection, Suspension · Ophthalmic | Bausch & Lomb Incorporated | 24208-0040-01 |
Other drugs in the same treatment class
These are different medicines — not other versions of Triamcinolone Acetonide Injection — that fall in the same broad treatment class (eye anti-inflammatory agents) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.
Identity & classification
Where does this data come from?
Other ophthalmology shortages
Triamcinolone Acetonide Injection shortage FAQs
Is Triamcinolone Acetonide Injection in shortage?
Which products are affected?
When will Triamcinolone Acetonide Injection be available again?
Can I still get Triamcinolone Acetonide somewhere?
What should I do if I take Triamcinolone Acetonide Injection?
Still have a question about the Triamcinolone Acetonide Injection shortage?
Ask a pharmacist about this shortage →View Triamcinolone Acetonide Injection on the FDA drug-shortage database →
Where does this data come from?
/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.